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Summary - The current study describes the results obtained from different methods
of detection of folate-sensitive fragile sites in goat chromosomes. Two  different types of
expression of chromosomal  fragility have  been  observed: telomeric non-staining  gaps, in 20
out of 21 animals studied, and chromatidic breaks in ten animals. The  non-staining gaps
have been identified mainly in chromosome 5, and their frequency of occurrence ranged
from 30 to 66% of the cells.  The chromatidic break occurrence ranged from 2 to 5%  of
the cells among  the break carriers. From the methods used and the observed frequency
of expression in cultures, the gaps were classified as common  folate-sensitive fragile sites.
Significant differences between the induction methods used were obtained. 
’
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Résumé - Induction  de  sites  chromosomiques  fragiles  chez  les  chèvres :  étude
préliminaire. Cette étude décrit les résultats de différentes méthodes de mise en évidence
de sites chromosomiques  fragiles sensibles au  folate chez la chèvre. Deux  types différents
d’expression de la fragilité chromosomique ont été observés : des espaces télomériques ne
prenant pas la coloration, sur 20 des 21 animaux étudiés,  et des cassures chromatidiques
sur 10 animaux. Les absences de coloration ont été localisées principalement sur le  chro-
mosome 5 et leur fréquence d’apparition allait de 30 à 66 %  des cellules.  Chez les por-
teurs de cassures, la fréquence de ces dernières allait de  2 à  5 % des cellules. D’après les
méthodes utilisées et les fréquences observées dans les cultures, les zones chromosomiques
non  colorées  peuvent  être considérées comme  appartenant à la catégorie commune  des sites
fragiles sensibles au folate. Des  différences significatives entre les méthodes d’induction ont
également été observées.
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About one hundred chromosomal fragile sites have been detected in humans  since
the first  description was made by Dekaban in  1965 (Sutherland,  1991). Human
fragile  sites  have been successively  related  to  different  pathologies and one of
the most well known  is the association between the mental retardation syndrome
and the fra.Xq27.3 (Sutherland and Baker, 1990; Vogel et al,  1990; Oberl6 et al,
1991; Craig, 1991). Furthermore, implications of chromosomal  fragility in different
processes like Bloom  syndrome (Fundia  et al, 1992), chromosomal  viral integration
points (Caporossi  et al, 1991), chromosomal  evolution (Mir6  et al, 1987; Popescu  et
al, 1990) and  the relationship between  fragile sites, oncogenesis and  tumoral  events
(Yunis,  1983; Yunis and Soreng,  1984; DeBraeckeler,  1987; Dal Cin et  al,  1991;
Austin et al,  1991) have been well documented in human  cytogenetics. In animals
only a  few  chromosomal  fragile sites have  been  reported, mainly  in domestic  species.
In pigs, Riggs and Chrisman (1989,  1991) have described aphidicolin and folate-
sensitive fragile sites like the ones detected by  Yan  and Long  (1993). More  recently,
folate,  5-BrdU and aphidicoline fragiles  sites have been found in equine, rabbit,
bovine, mole rat, dog and sheep karyotypes by Ronne (1992), Poulsen and Ronne
(1991), Uchida  et al (1986), Gripemberg (1991), Stone  et al (1991a) and  Matejka  et
al (1990). Although  no  close relationship with any  pathology  has  yet been  observed,
Tewari  et al (1987) have  indicated a  possible  effect on  the  fertility of  female  rats and
Stone et al (1991b) have suggested the implication of some  fragile sites in tumoral
chromosomal rearrangements in the mammary  glands of dogs. These features and
some  of the published results, indicate that the fragile sites may  be distributed in
the majority  of  domestic species in a  similar way  as for humans. This  highlights the
importance  of  knowing  the distribution and  morphological  characteristics of animal
fragile sites, as a  first step to finding the possible relationships between any  defined
pathology or syndrome and  the presence of chromosomal  fragility.
There is no knowledge of the induction methodologies or chromosomal fragility
expression forms in goats and the aim of this work has been the adaptation of
induction methodologies to begin studies of the detection and identification of
folate-sensitive fragile sites in this karyotype.
MATERIAL  AND  METHODS
Twenty-one adult goats were used, including Saanen, Toggenburg and cross-bred
animals.
An  adaptation of published protocols (Sutherland et al (1985); Howard-Peebles
(1991); Fisch et al (1991); Jacky et al (1991)) was used to induce the expression of
fragile sites in lymphocyte  cultures.
Whole  blood (1 mL)  was  cultivated in 10 mL  of  low  folate M-199  medium  (Flow)
supplemented with 5% SFB (Gibco), 1%  penicillin-streptomycin (Gibco), 5 IU of
PHA (phytohaemaglutinine)  (Wellcome) and 5 IU of Pokeweed (Gibco)-like mi-
togens. The culture pH was adjusted to 7.6-7.8 by the addition of bicarbonate.
Three modifications to this  basic  culture were used:  protocol  1:  5 vM of fluo-
rodeoxyuridine FdU  (Sigma, F  0530) and 30 mg/mL  of thymidine (Sigma, T  5018)were added during the last 24  h  of  cell culture; protocol 2: 5 R M  of fluorodeoxyuri-
dine (Sigma, F 5030), 30 mg/mL of thymidine (Sigma, T 5018) and 10 !g/mL
5-bromo-2’-deoxyuridine BrdU  (Sigma, B  5002) were added during the last 24 h  of
cell culture; protocol 3: 5 R M  of  fluorodeoxyuridine (Sigma, F  5030), 30 mg/mL  of
thymidine (Sigma, T  5018), and 10- 5 M  of amethopterin and  methotrexate (Sigma
A  6770) were added during the last 24 h  of  cell culture.
The  cultures were  harvested and  fixed according  to a  standard  technique (Moor-
head et al,  1960). Two  cultures for each treatment were made and 50 cells from
each one were observed. Control cultures were used for each protocol according to
the standard methodology: 1 mL  of whole blood in 10 mL  of RPMI  1640 (Gibco),
supplemented with 20% SFB (bovine  calf serum)  (Gibco)  and 1% penicilline-
streptomycin (Gibco) and 1% L -glutamine (Sigma). The cultures were incubated
at 37 °C in the absence of C0 2   and harvested after 72 h  of  growth.
The identification of chromosome pairs was accomplished by an adaptation of
the original Seabright’s G  banding method (Seabright, 1971). An  ANOVA  test was
used to establish the differences between treatments (Stat View, Macintosh).
RESULTS
Two  different types of chromosomal  alterations were observed. The  numbers  given
below  refer to protocol 3.
Non-staining  gaps at the telomeric region
The  results are  shown  in figure la  and  lb. The  minimum  expression  value  considered
was 4%  of the total observed cells, and only one animal presented an expression
percentage below this.  Among the  remaining  20,  the gaps were present  at  a
frequency of 30-66% of the cells,  with a mean value of 48.3 t  2.1%. Cells with
more than one gap occurred at a frequency ranging from 0-38%  of the total, with
a mean  value of 10.5 f  2.3% (table I).
After destaining and subsequent G-banding the autosome pair number 5 could
be identified as the main  carrier of gaps (fig 2a, 2b and  2c). In 18 animals (90% of
the 20), gaps on homologous chromosome 5 could be observed on this pair (fig 2a
and  2b). ..
Chromatidic breaks
The  occurrence of chromatidic breaks ranged from 0%  (breaks were detected only
in ten animals) to 4%, with a mean  value of 1.5 f 0.4% (table I). Unlike the gaps,
the break locations were detected in different regions and chromosome pairs, and
these ruptures were  observed in only one  chromatid  in all the analyzed cases (fig 3a
and  3b).
Methodologies used
The three variants described were useful for detecting gaps and break induction.
Considering  the ANOVA  test performed, treatment 3 showed  significant differences
(p <  0.05) from  treatments 1 and  2, taking  into account only gap  expression (fig 4).The  proliferation  cell rate was  lower when  protocol 2 was  employed. For  this reason,
another  comparison  test between  protocols 1 and  3 was  carried out using 18 animals
(fig 5). The ANOVA  test did not show  significant differences, but a slight increase
in gap expression in treatment 3 could be detected in both comparison tests (fig 4
and  5).
DISCUSSION
From a morphological point of view, the two types of lesions found can be con-
sidered as different chromosomal fragility expression forms in the goat karyotype.
The  high frequency of gaps and  the constancy of  their location are two  features in
agreement with the descriptions of other species whose gaps have been the most
frequent expression of chromosome  fragility. Matejka  et al (1990) reported a mean
value of 40%  expression for a BrdU  sensitive fragile site located at the eighth pair
in sheep, and Gripenberg et  al  (1991) detected up to 86% expression in a fra.X.
of deer. In humans  the fra.12q24.2 and fra.lOq25 are both  fragile sites with a high
level of  expression  in cultures (Voiculescou  et al, 1991; Tommerup  et al, 1981; Gollinet al, 1985). These  high  expression  values are  in agreement  with  the mean  expression
observed by us, and reinforce the fact that our results may  represent a common
folate-sensitive fragile site, which  shows  a chromosome  gap  as its form  of  expression
in cell culture.
Furthermore,  the  three protocol  modifications used  were  useful for gap  induction.
Even  though  some  of  the drugs used might have enhanced  the expression, it can be
pointed  out that the absence  of  folic acid  in the  culture medium  was  the main  factor
in provoking the fragile expression. A  slight positive effect on gap expression wasdetected  only when  methotrexate  was  added  24  h  before  harvesting (a  difference was
observed mainly when  a comparison was made  between treatments 1 and  3). If the
effect produced by amethopterin on the condensation and chromosome  elongation
is  considered (Laird et  al,  1987), an increase of the degree of stretching at the
fragile region, and consequently a clearer observation on optical microscopy, could
be a logical explanation for the observed high level of expression when  this drug  is
added.
Even  though  in some  animals (three), different chromosome  pairs were detected
to be telomeric gap carriers, their expression levels were <4%  of the cells and no
chromosome repetitive location was confirmed; only in the pair  5 were the gap
location and frequency expression values good enough to be considered a possible
expression of chromosomal fragility.  One important fact  is that the gaps overlap
the telomeric nucleolar organization region (NOR) in this pair. Consequently  it  is
necessary to assume  that any  stretching of  the NOR  region could provoke  a  variable
percentage  of  false-positive  fragile detection. In  this work  no  triple staining (Giemsa-
G-Banding-NORs) was employed, and  it is difficult to estimate what percentage of
gaps might be false-positive due to active NOR  regions being detected as fragile
sites, or indeed  if all the  fragile sites described  here  are only NOR  stretchings. There
is some  evidence that the latter is not the case. First, telomeric gaps were detected
only in one (pair 5) of the five chromosome  carriers of NORs  in goat (according to
Di Meo  et al,  1991) pairs 2,  3,  4,  5 and 28 are NORs  carriers in goats. Secondly,
the gaps were not limited to the telomere only, the gap region involving all the
telomeric positive R  or negative G  bands  of the carrier chromosome. The  gaps are
bigger than the NOR  region detected with normal AG-NOR  (silver staining NOR)
staining. These features indicate that it is not valid to assume  that all the gaps are
extensions of the NORs, though a percentage of false-positives due to this cannot
be excluded.
Telomeric Structural Changes (TSC) have been indicated as another source of
error when human  telomeric fragile sites are analyzed (Butler et al,  1990). These
TSC  are chromosomal  lesions which  can  be  detected as fragile sites and  the authors
mentioned that about 10%  of positive detection in human  fra.X is due  to this kind
of alteration. According to this it would be necessary to take into account another
variable percentage of error in the results observed.
The expression rate and the different positions of the breaks are subjects for
discussion. The breaks were not found in the control cultures and they presented
morphological features similar to some of the fragile  sites  described in humans
(isochromatidic  breaks  as  reported by  Sutherland  et al, 1985, and  Sutherland, 1991).
On  the other hand, in no case did the break frequency raise the minimum  level of
expression estimated in this work (4%) and only eleven animals expressed these
breaks with no repetition established in the position (a variation was noted in the
location within each chromosome and between chromosome  pairs).
Taking into account that the main  source of variation for the fragile expression
is related to the induction methodology (as described by Fisch et al,  1991 for the
fra.X syndrome in humans), the possibility that the methods used here caused a
higher rate of break or, in some  cases gap, inductions cannot be excluded.CONCLUSIONS
Although this  is  a preliminary study, some conclusions may be drawn. The ex-
pression of chromosomal fragility and its induction in goat karyotype are similar
to observations in related and unrelated species.  Furthermore, gaps seem to be
the main form of expression. Even though a combination of FdU  and a low folate
medium seems to be the only condition necessary for induction, some drugs like
amethopterin and thymidine are important for improving fragility expression in
this karyotype.
A  telomeric gap could be detected successfully only in pair 5;  according to its
expression frequency and  culture conditions  it could be  classified as a  virtual folate-
sensitive fragile site. Further study  is needed of  the sources of  error which can lead
to a significant  percentage of false-positive  results  (a combination of Telomeric
Structural Changes and NORs). A  study of its genetic inheritance is also required
to reach a  definitive conclusion.
It  is not possible to draw a conclusion about the chromatidic breaks detected.
The low frequency of expression and the variation in location on different chro-
mosome  pairs indicate that different induction methods are necessary for a better
understanding of the nature of their expression.
REFERENCES
Austin MJF  (1991) Expression of common  fragile sites on  the X  chromosome  corresponds
with active gene regions. Cancer Genet Cytogenet  54, 71-76
Butler MG, Allen GA, Haynes JL, Clark S (1990) Chromosome lesions which could be
interpreted as ’fragile sites’ on  the distal en of Xq. Am  J Med Genet  37, 250-253
Craig I (1991) Human  genetic-methylation and the fragile X. Nature 349, 742-743
Caporossi D, Bacchetti S,  Nicoletti B (1991) Synergism between aphidicolin and aden-
oviruses in the induction of breaks at fragile sites on human chromosomes.  Cancer
Genet Cytogenet 54, 39-53
Dal Cin P. De Wever I,  Moerman P, Van Den Berghe H  (1991) Translocation X;12 in
mesothelioma. Cancer Genet Cytogenet  55, 115-118
De  Braekeler M  (1987) Fragile  sites and  chromosomal  structural  rearreangements  in human
leukemia and  cancer. An,ticartcer Res  7,  141-142
Di Meo  GP, Iannuzzi L, Ferrara L, Rubino R  (1991) Identification of nucleolus organizer
chromosomes in goat (Capra hircus).  Caryologia  44, 309-316
Fisch GS, Silverman W,  Jenkins EC  (1991) Genetic and other factors that contribute to
variability in cytogenetic expression in fragile X  males. Am  J Med Genet  38, 404-407
Fundia AF, Gorla NB, Bonduel MM,  Azpelicueta 0, Lejarraga H, Sackman  F, Larripa I
(1992) Increased expression of 5q31 fragile site in a Bloom syndrome family. Human
Genet  89, 569-572
Gollin  SM, Holmquist  GP, Ledbetter DH (1985)  Fra  (10)(q25):  the  BrdU effect  is
substitution-dependent. Am  J Hum  Genet  37, 208-214
Gripenberg U, Huuhtanen S, Wessman M, Nieminen M  (1991) A  fragile site in the X
chromosome  of the reindeer (Rangifer tara!cdus L). Genet Sel Evol  23, 135s
Howard-Peebles PN  (1991) Fragile X  expression: use of a double induction system. A!n J
Med Genet  38, 445-446
Jacky PB  (1991) Guidelines for the preparation and  analysis of  the  fragile X  chromosomes
in lymphocytes. Am  J Med Genet  38, 400-403Laird CD  (1987) Proposed mechanism  of  inheritance and  expression of  the human  fragile-
X-syndrome  of mental retardation. Genetics 117, 587-599
Matejka M, Cribiu EP, Ricordeau G, Eychenne Durand V, Lajous D, Darre R  (1990)
Evidence  for rare heritable fragile site in Romanof  sheep chromosome  8. Reprod Domest
Anim  25, 227-234
Mir6  S, Clemente  IC, Fuster C, Egozcue  J (1987) Fragile sites, chromosome  evolution and
human  neoplasia. Hum  Genet  73, 345-349
Moorhead PS, Nowell PC, Mellman NJ, Battips J,  Hungerford M  (1960) Chromosome
preparation of leukocytes cultured from human peripheral blood.  Exp Cell Res 20,
613-616
Oberlé  I,  Rousseau F,  Heitz  D,  Kretz  D,  Devys D,  Hanauer A,  Boue J,  Bertheas
MF, Mandel JL (1991)  Instability of a 550-base pair DNA  segment and abnormal
methylation in fragile X  syndrome. Science 252, 1097-1102
Popescu NC, Zimonjic D, Di Paolo J (1990) Viral integration,  fragile sites and proto-
oncogenes in human  neoplasias. Human  Genetics 84, 383-386
Poulsen BS, Ronne M. (1991) High-resolution banding and localization of fragile sites in
Oryctolagv,s cunicv,lus.  Genet Sel Evol  23, 183s
Riggs PK, Chrisman CL (1989) Preliminary analysis of aphidicolin-induced fragile sites
in goat chromosomes. Sixth North American Colloqiv,m on Cytogenetics on Domestic
Animals, West Lafayette, IN, abstr 4
Riggs PK, Chrisman CL (1991)  Identification  of aphidicolin-induced  fragile  sites  in
domestic pig chromosomes. Genet Sel Evol  23, 187s
R o nne  M  (1992) Putative fragile sites in horse karyotype. Hereditas 117, 127-136
Seabright M  (1971) A  rapid banding  technique  for human  chromosomes. Lancet  II, 971-972
Shuterland GR,  Baker  E, Fratini A  (1985) Excess  thymidine  induces  folate sensitive fragile
sites. Am  J Med Genet  22, 433-443
Stone DM,  Jacky  PB, Hancock DD,  Prieur D  (1991a) Chromosomal  fragile site expression
in dogs: I.  Breed-specific differences. Am  J  Med  Genet  40, 214-222
Stone DM,  Jacky  PB, Hancock  DD,  Prieur D  (1991b) Chromosomal  fragile site expression
in dogs: II. Expression in boxer dogs with mast  cell tumors. Am J  Med  Genet  40, 223-
229
Sutherland GR  (1991) Chromosomal  fragile sites. Review. In: Genetic  Analysis Techniques
and  Applications 8, 161-166
Sutherland GR, Baker E (1990) The common  fragile site in band q27 of the human X
chromosome  is not coincident with the fragile X. Clin Genet  37, 167-172
Tewari  R, Juyal RC, Thelma  BK,  Das  BC, Rao  SRV  (1987) Folate-sensitive fragile sites on
the X-chromosome  heterochromatin  of  the Indian mole  rat Nesokia indica. Gytogen.etic
Cell Genet  44, 11-17
Tommerup N, Poulsen H, Nielsen KB (1981)  5-Fluoro-2-deoxyuridine induction of the
fragile site on Xq28 associated with X-linked mental retardation.  J Med Genet 18,
373-376
Uchida  IA, Freeman  VCP,  Basrur PK  (1986) The  fragile X  in cattle. Am  J  Med  Genet  23,
557-562
Vogel F, Crusio WE,  Kovacs C, Fryns JP, Freund M  (1990) Selective advantage  of fra(X)
Heterozygotes. Hum  Genet  86, 25-32
Voiculescou I,  Back E, Schempp W  (1991) Homozygous condition for a BrdU-requiring
fragile site on chromosome 12. Hum  Genet  86, 416-417
Yang MY, Long SE (1993) Folate sensitive fragile sites in chromosomes of the domestic
pig (Sus scrofa). Res Vet Sci 55, 231-235
Yunis J (1983) The  chromosomal basis of human  neoplasia. Science 221, 227-236
Yunis J, Soreng AL  (1984) Constitutive fragile sites and cancer. Science 26, 1199-1204